| Nov 3 2023 |
Updates to the Washington Paid Family and Medical Leave Program |
Jackson Lewis P.C. |
| Nov 3 2023 |
Legislature Amends Law Permitting Collective Bargaining Negotiations Involving Certain Aspects of Health Care Plan Design and Coverage |
von Briesen & Roper, s.c. |
| Nov 3 2023 |
FDA LDT Webinar Serves as a Reminder to Industry to Submit Comments on the Proposed Rule |
Epstein Becker & Green, P.C. |
| Nov 3 2023 |
CMS Adds Place of Service to Allow Additional Flexibility in Delivering Medicare and Medicaid Healthcare Services to the Homeless |
Epstein Becker & Green, P.C. |
| Nov 3 2023 |
Medical Marketer Convicted of $55 Million Fraud Scheme |
ArentFox Schiff LLP |
| Nov 2 2023 |
Biden Executive Order Calls for HHS to Establish Health Care-Specific Artificial Intelligence Programs and Policies |
Mintz |
| Nov 2 2023 |
Rare DOJ Criminal Indictment Related to Medicare Advantage Risk Adjustment |
Epstein Becker & Green, P.C. |
| Nov 2 2023 |
HHS-OIG Issues Unfavorable Opinion Saying Offering Free Hearing Aid With Cochlear Implant Presents Risk Of Fraud, Abuse |
Barnes & Thornburg LLP |
| Nov 2 2023 |
CMS Announces 0.8 Percent Aggregate Home Health Payment Increase in 2024 |
Robinson & Cole LLP |
| Nov 2 2023 |
Competition Currents | November 2023 |
Greenberg Traurig, LLP |
| Nov 2 2023 |
2024 Cost of Living Adjustments |
Varnum LLP |
| Nov 2 2023 |
The PACE Solution to Increasing Demands for Long-Term Services and Supports in the U.S. |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 2 2023 |
Attention! Important New Decision on Accrual of Paid Leave in France |
Squire Patton Boggs (US) LLP |
| Nov 2 2023 |
Diagnosing Health Care Podcast – Episode 71: Dietary Supplements – Navigating the Regulatory Maze [Podcast] |
Epstein Becker & Green, P.C. |
| Nov 1 2023 |
Landmark Executive Order on AI: What Does it Mean for Healthcare? |
McDermott Will & Emery |
| Nov 1 2023 |
IRS Announces 2024 Employee Benefit Plan Limits |
McDermott Will & Emery |
| Nov 1 2023 |
Hospital Mergers: The Value and Pitfalls |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 1 2023 |
The Increasing Trend of Chinese Asylum-Seekers at the US Border |
Norris McLaughlin P.A. |
| Nov 1 2023 |
OIG Issues Unfavorable Advisory Opinion on Free Items to Patients Tied to Reimbursable Services |
Mintz |
| Nov 1 2023 |
HHS Proposes Disincentives for Providers that Commit Information Blocking |
Robinson & Cole LLP |
| Nov 1 2023 |
White House Executive Order on Artificial Intelligence: Implications for the Health Care and Life Sciences Industries |
Epstein Becker & Green, P.C. |
| Oct 31 2023 |
Options for Menopause Benefits for Employees |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Oct 31 2023 |
CMS Announces New Guide Model for People Living with Dementia and Their Caregivers |
McDermott Will & Emery |
| Oct 31 2023 |
Significant Changes to Massachusetts Paid Family Leave Coming on November 1, 2023 |
ArentFox Schiff LLP |
| Oct 31 2023 |
Safety Perspectives From Region 6: Tales and Lessons From the Field |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Oct 31 2023 |
California Takes Steps Towards a Unified Health Care Financing System |
Squire Patton Boggs (US) LLP |
| Oct 31 2023 |
Top Takeaways | 2023 PPM-ASC Symposium | Specialty Spotlight: Behavioral Health |
McDermott Will & Emery |
| Oct 31 2023 |
FDA: New Draft Guidance on Communication of Unapproved Uses of Approved or Cleared Medical Products |
Foley & Lardner LLP |
| Oct 31 2023 |
Massachusetts Department of Paid Family and Medical Leave Revises Guidance on Topping Off Benefits With Accrued Paid Leave |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Oct 30 2023 |
Healthcare Preview for the Week of: October 30, 2023 |
McDermott Will & Emery |
| Oct 30 2023 |
Guidance from FDA Clarifies a Key Issue for Industry: Non-Promotional Presentations About Unapproved Uses of Medical Products Can Be Produced by the Products’ Sponsors Without Violating Off-Label Rules |
Mintz |
| Oct 30 2023 |
Don’t Leave Money on the Table from Your Pandemic-Era Healthcare Procurement Contract |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 30 2023 |
Fast 5: Five Quick Regulatory Takeaways for Pharmaceutical Companies |
ArentFox Schiff LLP |
| Oct 30 2023 |
District of Massachusetts Split on Causation Standard in Kickback FCA Cases |
Bradley Arant Boult Cummings LLP |
| Oct 30 2023 |
HRSA Confirms End of COVID Waiver of Advance Registration Requirement for Provider-Based Clinics |
Robinson & Cole LLP |
